Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
107,800,271
-
Total 13F shares
-
52,839
-
Share change
-
-94,370,779
-
Total reported value
-
$4,154,495
-
Price per share
-
$105.26
-
Number of holders
-
4
-
Value change
-
-$12,449,682,474
-
Number of sells
-
386
Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q2 2025
As of 30 Jun 2025,
Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,839 shares.
The largest 4 holders included
DekaBank Deutsche Girozentrale, OSAIC HOLDINGS, INC., Kestra Investment Management, LLC, and HUNTINGTON NATIONAL BANK.
This page lists
4
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.